Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Finished Goods (2020 - 2026)

Bioventus filings provide 6 years of Finished Goods readings, the most recent being $61.0 million for Q4 2025.

  • On a quarterly basis, Finished Goods fell 13.33% to $61.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $61.0 million, a 13.33% decrease, with the full-year FY2025 number at $61.0 million, down 13.33% from a year prior.
  • Finished Goods hit $61.0 million in Q4 2025 for Bioventus, down from $74.4 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $75.0 million in Q3 2023 to a low of $31.5 million in Q3 2021.
  • Median Finished Goods over the past 5 years was $65.9 million (2022), compared with a mean of $60.9 million.
  • Biggest five-year swings in Finished Goods: surged 93.01% in 2021 and later fell 13.33% in 2025.
  • Bioventus' Finished Goods stood at $50.8 million in 2021, then surged by 30.52% to $66.3 million in 2022, then grew by 5.97% to $70.3 million in 2023, then rose by 0.15% to $70.4 million in 2024, then decreased by 13.33% to $61.0 million in 2025.
  • The last three reported values for Finished Goods were $61.0 million (Q4 2025), $74.4 million (Q3 2025), and $73.0 million (Q2 2025) per Business Quant data.